謝瑞麟(00417.HK)預計中期盈利不少於約200萬港元 同比扭虧
格隆匯10月13日丨謝瑞麟(00417.HK)公佈,預計集團截至2021年9月30日止六個月將錄得公司擁有人應占盈利不少於約200萬港元(對比截至2020年9月30日止六個月的公司擁有人應占虧損約4200萬港元)。
董事會認為集團業績由虧轉盈,乃因中國內地2019冠狀病毒病疫情在可控範圍內保持穩定,集團業務的整體表現得以陸續復甦,及集團持續執行多項成本節省措施令開支減少所帶來的綜合效果。於回顧期間,集團亦大力推動線上業務發展,公司的電子商貿業務因而錄得顯著增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.